Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Welsh

Showing results (371-380 of 524) with videos related to

Pageof 53
Sort By:
JACC. Advances|March 19, 2026
Mechanisms Underlying Reduced Peak Oxygen Uptake in Older Long-Term Breast Cancer SurvivorsStephen J Foulkes, Edith Pituskin, Thomas McMurtry, et al.
American Heart Journal|February 15, 2011
Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE)Jeremy Edwards, Shaun G Goodman, Raymond T Yan, et al.
The American Journal of Cardiology|September 18, 2020
Cardiac Stress Testing After Coronary RevascularizationArti Dhoot, Shuangbo Liu, Anamaria Savu, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 17, 2014
Neurocognitive function after (chemo)-radiotherapy for head and neck cancerL C Welsh, A W Dunlop, T McGovern, et al.
The Canadian Journal of Cardiology|October 17, 2016
Quality of Care for Percutaneous Coronary Intervention: Development of Canadian Cardiovascular Society Quality IndicatorsAta Ur Rehman Quraishi, Laurie J Lambert, Mina Madan, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionRobert C Welsh, Christopher B Granger, Cynthia M Westerhout, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 20, 2022
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA RegistryKeith A A Fox, Victor Aboyans, E Sebastian Debus, et al.
Journal of Clinical and Experimental Neuropsychology|July 31, 2009
Prechemotherapy alterations in brain function in women with breast cancerBernadine Cimprich, Patricia Reuter-Lorenz, James Nelson, et al.
Plastic and Reconstructive Surgery|November 30, 2021
Hyaluronic Acid Embolism Treated with Subcutaneous High and Low Hyaluronidase Doses: Efficacy and Surrounding Tissue EffectYolanda Salinas-Alvarez, Esperanza C Welsh, Adolfo Soto-Dominguez, et al.
Neuroimage|September 2, 2018
Amygdala habituation and uncinate fasciculus connectivity in adolescence: A multi-modal approachTyler C Hein, Whitney I Mattson, Hailey L Dotterer, et al.
Pageof 53

Showing results (371-380 of 524) with videos related to

Sort By:
Pageof 53
JACC. Advances|March 19, 2026
Mechanisms Underlying Reduced Peak Oxygen Uptake in Older Long-Term Breast Cancer SurvivorsStephen J Foulkes, Edith Pituskin, Thomas McMurtry, et al.
American Heart Journal|February 15, 2011
Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE)Jeremy Edwards, Shaun G Goodman, Raymond T Yan, et al.
The American Journal of Cardiology|September 18, 2020
Cardiac Stress Testing After Coronary RevascularizationArti Dhoot, Shuangbo Liu, Anamaria Savu, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 17, 2014
Neurocognitive function after (chemo)-radiotherapy for head and neck cancerL C Welsh, A W Dunlop, T McGovern, et al.
The Canadian Journal of Cardiology|October 17, 2016
Quality of Care for Percutaneous Coronary Intervention: Development of Canadian Cardiovascular Society Quality IndicatorsAta Ur Rehman Quraishi, Laurie J Lambert, Mina Madan, et al.
JACC. Cardiovascular Interventions|March 20, 2010
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionRobert C Welsh, Christopher B Granger, Cynthia M Westerhout, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 20, 2022
Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA RegistryKeith A A Fox, Victor Aboyans, E Sebastian Debus, et al.
Journal of Clinical and Experimental Neuropsychology|July 31, 2009
Prechemotherapy alterations in brain function in women with breast cancerBernadine Cimprich, Patricia Reuter-Lorenz, James Nelson, et al.
Plastic and Reconstructive Surgery|November 30, 2021
Hyaluronic Acid Embolism Treated with Subcutaneous High and Low Hyaluronidase Doses: Efficacy and Surrounding Tissue EffectYolanda Salinas-Alvarez, Esperanza C Welsh, Adolfo Soto-Dominguez, et al.
Neuroimage|September 2, 2018
Amygdala habituation and uncinate fasciculus connectivity in adolescence: A multi-modal approachTyler C Hein, Whitney I Mattson, Hailey L Dotterer, et al.
Pageof 53